• investor-relations-raising-capital
    Clear strategy, credible valuation, and pitch-perfect execution
    Smart capital is earned with
    strategy, precision, and the right materials in hand
Investors, Funds, Capital, Family Offices, Professional Investors, contacts life sciences biotech pharma
Raising capital isn’t just about funding — it’s about telling the right story to the right investors.
Success in fundraising depends on sharp positioning, compelling materials, and strategic investor engagement.
senior appointments executive search medtech digital health biotech pharma
Expert Support for Fundraising in Life Sciences

Raising Capital

Securing funding in today’s market is one of the biggest challenges for biotech and pharma companies. Investors are more selective, timelines are longer, and competition is fierce. Yet, raising capital is critical.

DyoDelta specialises in supporting companies that are need to raise funds, whether through private placements, venture capital, IPOs, or family offices. We are not brokers - we are experienced partners who’ve sat in your seat and know what it takes to succeed.

Our approach is designed to optimise your fundraising materials, refine your strategy, and connect you to relevant, qualified investors who understand your value proposition.

- Investor-ready positioning & messaging

- Valuation modelling & sales forecasts

- Professional business plans & TPP development

- Investor presentations & pitch deck optimisation

- Deal collateral tailored for institutional and retail audiences

- Fundraising strategy & investor targeting

- Support for IPO or alternative financing paths

- Warm introductions to life sciences investors, VCs, and family offices

Our expertise extends across all financing stages, from seed to Series A/B/C/D, pre-IPO, and public market listings, with experience across Europe, North America, and Asia.



OUR CORE COMPETENCIES AND LONG EXPERIENCE IN THE SECTOR

Why Choose DyoDelta

Unlike generalist advisors or design firms, we focus on substance first: the strategy, story, positioning, and valuation assumptions — all backed by credible market data. Once the narrative is sharp, we help you package it in a compelling, investor-friendly way.

Importantly, our team is made up of former biotech CEOs, dealmakers, and pharma execs, not graphic designers or career consultants. We understand what investors want to see; and what makes them ignore you.

We are not brokers or placement agents. We do not charge a percentage or rely on success fees. Instead, we operate as trusted advisors who work with you over a defined period, often on a monthly retainer, delivering high-value, independent strategic input.

This model gives you access to:


Real, hands-on support across investor interactions


A sharper value story to maximise valuation


A process that protects your time and credibility



This is how serious biotech companies prepare, and how real investors take notice.

Beyond Capital


Fundraising is not just about money, it’s about setting your company up for long-term success.

Investors back great science, but they also back clear strategy, solid management, and smart execution. We help you build investor confidence across every touchpoint.

Whether you’re preparing for a Series A, exploring an IPO, or re-engaging a stale process, we can help you regain control, raise funding with purpose, and protect your valuation.
drug discovery development executive search

Our Capital Readiness Process

Strategic Review

- Clarify positioning

- Evaluate pipeline maturity

- Stress-test TPPs and value drivers

Communications Strategy

- Rebuild or revise investor deck and key messaging

- Develop robust financial and valuation models

- Create supporting material for deeper due diligence

Targeting & Outreach

- Identify and prioritise investor types

- Introduce select opportunities to our network

- Guide follow-ups and meetings with credibility

Ongoing Guidance

- Help respond to due diligence questions

- Optimise momentum and narrative throughout process

- Advise on deal structure and valuation conversations

Get Started

If you're preparing to raise capital and want to put your best foot forward — talk to us.

We'll give you clear, honest advice, and if we think we can help, we’ll roll up our sleeves and work with you like part of the team.

We are a Life Sciences advisory UK company based in London, assisting companies and investors in Pharma, Biotech, MedTech and HealthTech. We specialise in providing full-service support in Business Development & Licensing deals, Product Development, Financing, Commercialisation and Communications.

Core Areas

  • Corporate Deals
  • Investor Support
  • Communications
  • Investor Relations
  • Market & Sales Forecasts
  • Valuation
  • Due Diligence
  • Portfolio Prioritisation
  • M&A and IPOs
  • Financing
  • Investor Pitch Decks
  • Business Plans

Quick Links

Contact Us


Address:
DyoDelta Biosciences Ltd
33 St James's Square
London SW1Y 4JS
U.K.
Phone: +44 20 3239 3022
Email: enquiries @ dyodelta . com

[remove spaces between words]

© 2025 DyoDelta Biosciences Ltd . | All rights reserved. | Terms | Website Design by PharmaWebsites